875
Views
11
CrossRef citations to date
0
Altmetric
Review

Current and emerging long-acting antipsychotics for the treatment of schizophrenia

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , & ORCID Icon show all
Pages 771-790 | Received 14 Nov 2020, Accepted 26 Mar 2021, Published online: 12 Apr 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jeremy Mills. (2023) More than a Half-Century with Haloperidol: Glories, Disparities, and Use Today. Issues in Mental Health Nursing 44:1, pages 83-87.
Read now
Renato de Filippis, Raffaele Gaetano, Georgios Schoretsanitis, Giuseppe Verde, Cesare Anthony Oliveti, John M Kane, Cristina Segura-Garcia & Pasquale De Fazio. (2021) Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile. Neuropsychiatric Disease and Treatment 17, pages 2141-2150.
Read now

Articles from other publishers (9)

Giuseppe Cicala, Renato de Filippis, Maria Antonietta Barbieri, Paola Maria Cutroneo, Pasquale De Fazio, Georgios Schoretsanitis & Edoardo Spina. (2023) Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database. Frontiers in Psychiatry 14.
Crossref
Lindsey Peters, Megan Dyer, Emily Schroeder & Manoranjan S. D’Souza. (2023) Invega Hafyera (Paliperidone Palmitate): Extended-Release Injectable Suspension for Patients With Schizophrenia. Journal of Pharmacy Technology 39:2, pages 88-94.
Crossref
Patricia Viera de Oliveira, Otavio Sanaiotto, Ketelin Zamin Kuhn, Amanda Oltramari, Adailton J. Bortoluzzi, Marcelo Lanza, Gean Pablo S. Aguiar, Anna Maria Siebel, Liz Girardi Müller & J. Vladimir Oliveira. (2023) Micronization of naringenin in supercritical fluid medium: In vitro and in vivo assays. Journal of Drug Delivery Science and Technology 82, pages 104382.
Crossref
Renato de Filippis, Filippo Antonio Staltari, Matteo Aloi, Elvira Anna Carbone, Marianna Rania, Laura Destefano, Luca Steardo Jr., Cristina Segura-Garcia & Pasquale De Fazio. (2023) Effectiveness of SGA-LAIs on Clinical, Cognitive, and Social Domains in Schizophrenia: Results from a Prospective Naturalistic Study. Brain Sciences 13:4, pages 577.
Crossref
Renato de Filippis, Mireia Solerdelcoll & Mohammadreza Shalbafan. (2023) Editorial: Safety and side effects of psychotropic medications. Frontiers in Psychiatry 14.
Crossref
Antonio Vita, Andrea Fagiolini, Giuseppe Maina, Claudio Mencacci, Edoardo Spina & Silvana Galderisi. (2023) Achieving long-term goals through early personalized management of schizophrenia: expert opinion on the role of a new fast-onset long-acting injectable antipsychotic. Annals of General Psychiatry 22:1.
Crossref
Janine Wilkinson, Damilola Ajulo, Valeria Tamburrini, Gwenaelle Le Gall, Kristof Kimpe, Rene Holm, Peter Belton & Sheng Qi. (2022) Lipid based intramuscular long-acting injectables: Current state of the art. European Journal of Pharmaceutical Sciences 178, pages 106253.
Crossref
Renato de Filippis, Michele Mercurio, Giovanna Spina, Pasquale De Fazio, Cristina Segura-Garcia, Filippo Familiari, Giorgio Gasparini & Olimpio Galasso. (2022) Antidepressants and Vertebral and Hip Risk Fracture: An Updated Systematic Review and Meta-Analysis. Healthcare 10:5, pages 803.
Crossref
Andrea Aguglia, Laura Fusar-Poli, Andrea Amerio, Valeria Placenti, Carmen Concerto, Giovanni Martinotti, Giuseppe Carrà, Francesco Bartoli, Armando D'Agostino, Gianluca Serafini, Mario Amore, Eugenio Aguglia, Giovanni Ostuzzi & Corrado Barbui. (2021) The Role of Attitudes Toward Medication and Treatment Adherence in the Clinical Response to LAIs: Findings From the STAR Network Depot Study. Frontiers in Psychiatry 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.